Gelonghui, April 22丨Shandong Pharmaceutical (600529.SH) released its report for the first quarter of 2024. Operating revenue for the reporting period was 1,267 million yuan, up 2.50% year on year; net profit attributable to shareholders of listed companies was 221 million yuan, up 32.59% year on year; after deducting non-net profit of 210 million yuan, up 36.14% year on year; basic earnings per share were 0.33 yuan.
山东药玻(600529 .SH)：一季度净利润2.21亿元 同比增长32.59%
Shandong Pharmaceutical (600529.SH): Net profit of 221 million yuan in the first quarter increased 32.59% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.